Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea
Journal of Veterinary Pharmacology and Therapeutics · 2022-11 · 45 (6) · 508-515
DOI: 10.1111/jvp.13087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 28.07.2022. Verfasst von Cindy K Sotelo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Ondansetron, Antiemetics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Private donation from Dr. Nicholas Booth.
Abstract (Originalsprache)
The purpose of this study was to evaluate the pharmacokinetics of intravenous (IV) ondansetron in a population of hospitalized dogs exhibiting clinical signs of nausea. The causes of nausea included pancreatitis, gastroenteritis, endocarditis, chemotherapy‐induced nausea, diabetes mellitus and ketoacidosis, acute kidney injury with aspiration pneumonia, pyometra, uroabdomen, neoplasia, and hepatopathy. Twenty‐four dogs were randomly assigned to one of the following IV ondansetron protocols: 1 mg/kg q12h, 0.5 mg/kg q12h, 1 mg/kg q8h, 0.5 mg/kg q8h. Serum was collected at 0, 0.25, 0.5, 1, 2, 4, 8, 16, and 24 h after the first dose, and nausea scores were recorded at multiple time points. Ondansetron and arginine vasopressin (AVP) concentrations were measured via high‐performance liquid chromatography coupled to tandem mass spectrometry and ELISA, respectively. Noncompartmental pharmacokinetic modeling and dose interval modeling were performed. Ondansetron displayed linear pharmacokinetics. In the 0.5 mg/kg group, mean C max = 214 ng/ml, AUC 0–8h = 463 ng/ml*h, and calculated half‐life was 1.9 h. In the 1 mg/kg group, mean C max = 541 ng/ml, AUC 0–8h = 1057 ng/ml*h and calculated half‐life was 1.6 h. Serum ondansetron concentrations were not significantly different between dogs that required rescue anti‐nausea medication (non‐responders) and dogs that did not require rescue therapy (responders). In total, 83.3% of patients in the 0.5 mg/kg q8h, 0.5 mg/kg q12h, and 1 mg/kg q8h groups had improvement in nausea scores. In total, 66.7% of patients in the 1 mg/kg q12h group had improvement in nausea scores. In total, 33% of patients had resolution of nausea in the 0.5 mg/kg q8h, 1 mg/kg q8h, and 1 mg/kg q12h groups, and 16% of patients had resolution of nausea in the 0.5 mg/kg q12h group. AVP concentrations were highly variable and did not correlate with nausea scores. Nausea scores significantly decreased regardless of dosage protocol. AVP was not a reliable biomarker of nausea in this group of dogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Kristin M Zersen
Förderung
- Private donation from Dr. Nicholas Booth
Zitieren
APA
Sotelo, C. K., Shropshire, S. B., Quimby, J., Simpson, S., Gustafson, D. L., & Zersen, K. M. (2022). Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea. Journal of Veterinary Pharmacology and Therapeutics, 45(6), 508-515. https://doi.org/10.1111/jvp.13087
Vancouver
Sotelo CK, Shropshire SB, Quimby J, Simpson S, Gustafson DL, Zersen KM. Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea. Journal of Veterinary Pharmacology and Therapeutics. 2022;45(6):508-515. doi:10.1111/jvp.13087
BibTeX
@article{Sotelo2022,
author = {Sotelo, Cindy K and Shropshire, Sarah B and Quimby, Jessica and Simpson, Sydney and Gustafson, Daniel L and Zersen, Kristin M},
title = {Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2022},
volume = {45},
number = {6},
pages = {508--515},
doi = {10.1111/jvp.13087}
}
EUVIMED